fda compounded semaglutide decision warns about versions of semaglutide, used for diabetes, weight loss FDA restricts non-approved compounded GLP-1

Skyrocketing sales for weight loss drugs known as GLP-1s, first made popular via the diabetes treatment Ozempic, have had ripple effects across the global economy

The mechanism also explains why medical oversight matters

Morgan Stanley $MS (MS) analysts project that the global market for GLP-1 prescription drugs could reach $105 billion by 2030

The drugs appetite suppression makes hitting a 1,500-plus calorie deficit by accident easy, so plan meals rather than eating to appetite

Anti-Aging : Peptides such as collagen peptides, GHK-Cu, and Epithalon can improve skin elasticity, reduce wrinkles, and promote a youthful appearance

Zaghloul, Wael B